TYLIFA Trademark

Trademark Overview


On Wednesday, April 13, 2022, a trademark application was filed for TYLIFA with the United States Patent and Trademark Office. The USPTO has given the TYLIFA trademark a serial number of 97362003. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 10, 2023. This trademark is owned by Iovance Biotherapeutics, Inc.. The TYLIFA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals, biological preparations and diagnostic preparations

Medical services; medical diagnostic services; medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations
tylifa

General Information


Serial Number97362003
Word MarkTYLIFA
Filing DateWednesday, April 13, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, biological preparations and diagnostic preparations
Goods and ServicesMedical services; medical diagnostic services; medical treatment of cancer via the modification of cells; medical services, namely, medical services for the treatment of a wide range of diseases and medical conditions via the modification of cells; medical services in the field of immunotherapy treatments; medical diagnosis and treatment of immune system related diseases and disorders; medical services, namely, medical services for the diagnosis and treatment of a wide range of diseases and medical conditions; providing medical information relating to oncology and immunotherapy treatment; providing medical information; medical consultations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIovance Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070

Trademark Events


Event DateEvent Description
Wednesday, May 10, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 10, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, May 10, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, October 19, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 16, 2022NEW APPLICATION ENTERED